Concerned about your own or
someone else’s drug use?


To build scope & capacity
for clinical research

The next NCCRED Symposium will be held online on...

Friday 20th November 2020

Innovations in therapeutic practice

Having held our inaugural symposium last year as part of APSAD in Hobart, NCCRED will host its second symposium on Friday 20th November.

We wish we could see you all face to face, but this year it will be done virtually to accommodate COVID-19 restrictions. We thought it was still important to gather in whatever way we can.

The 2020 symposium will focus on innovations in the therapeutic practice for methamphetamine disorder. The symposium brings together leading national researchers, including presentations from recipients of NCCRED’s Round 2 Seed Funding Program. The four recipients will share the most up-to-date aspects of their work and research around emerging drug use. Areas of exploration in the 2020 symposium include:

  • New directions in pharmacotherapy for methamphetamine withdrawal
  • Networks and referral pathways for people with methamphetamine dependence
  • Emerging national drug monitoring networks

NCCRED’s 2020 symposium, in line with the Centre’s aims, is a vital opportunity for the AoD sector to advance its collective response to emerging drugs:

  • Collaborate to build and expand research networks and capacity
  • Generate the best evidence-based knowledge
  • Translate the latest research into best clinical practice

We look forward to seeing you at our 2020 symposium.

The full program and registrations will be available soon.

Dr. David Goodman-Meza

International Guest Presenter
David Goodman-Meza, MD, MAS, is an Assistant Professor in the Division of Infectious Diseases at the David Geffen School of Medicine at University of California, Los Angeles, USA. Dr. Goodman-Meza is a
Read more

Collaborate, Generate, Translate: Research meets clinical practice in methamphetamine and emerging drugs

In line with NCCRED’s aims, the symposium was designed to:

  • Collaborate to build research networks and capacity
  • Generate evidence-based knowledge
  • Translate research into best clinical practice

We gathered vastly experienced clinicians and researchers from some of the major drug and alcohol centres around the country. The program included presentations from Round 1 NCCRED Clinical Research Seed Funding Grant recipients, NCCRED Clinical Research Capacity Building Grant recipients, the NCCRED team and affiliates. They shared the most up-to-date aspects of their work and research around emerging drug use, including:

  • Drug monitoring and response networks around Australia
  • Treatment outcomes and methods
  • Future research priorities

Check out the program:


2019 Presentations

  1. Dr Krista Siefried, Clinical Research Lead, National Centre for Clinical Research on Emerging Drugs (NCCRED): A rapid clinical research priority assessment for substance use disorders due to methamphetamine and emerging drugs of concern in Australia
  2. Dr Emma Partridge, Forensic Scientist, Forensic Science SA: Results of the South Australian Drug Early Warning System – Emergency Department Admission Blood Psychoactive Testing (EDABPT) Study
  3. Dr Chris Tremonti, Advanced Trainee in Addiction and Pharmacology, Royal Prince Alfred Hospital: A randomised double-blind placebo-controlled study of Lisdexamfetamine for the treatment of methamphetamine dependence (LiMA) – RPAH experience of participant recruitment and retention
  4. Emma Black, Senior Project Officer, Drug and Alcohol Services, The Langton Centre: Characteristics and treatment outcomes of the drug treatment population in New South Wales – focus on amphetamine type stimulants (ATS)
  5. Dr Sandra Mitchell, Prompt Response Research Fellow, National Centre for Clinical Research on Emerging Drugs (NCCRED): Towards a prompt response network for Australia: rapid health communication about events related to emerging drugs of concern
  6. Roger Nicholas, Senior Researcher, National Centre for Education and Training on Addiction, Flinders University: The National Centre for Clinical Research on Emerging Drugs: Clinical Research Workforce Development Strategy
  7. Dr Craig Rodgers, Senior staff specialist, Alcohol and Drug Service, St Vincent’s Hospital Sydney: Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service
  8. Dr Briony Larance, Senior Research Fellow, University of Wollongong & Sarah Adams, Clinical Psychologist, Illawarra Drug and Alcohol Services: Drawing on regional data analytics and stakeholder consultation to improve responses to methamphetamine-related harm in a New South Wales Local Health District
  9. Dr Jessamine Soderstrom, Clinical Toxicologist, Emergency Physician, Royal Perth Hospital: Emerging Drug Network of Australia
  10. Liam Acheson, Research Officer, St Vincent’s Hospital Sydney: Optimising Care for People Who Inject Drugs: A retrospective medical record review of staphylococcus aureus bacteraemia treatment